1.Squamous cell carcinoma in bladder exstrophy: a rare entity.
Sachin PATIL ; Sudhir Kumar JAIN ; Ramchandra KAZA ; Seema RAO
Singapore medical journal 2012;53(12):e254-7
Carcinomas arising from an exstrophic urinary bladder are rare entities, and only seven such cases have been reported in the literature. We present the eighth case of advanced squamous cell carcinoma arising from an exstrophic bladder, with a pertinent review of the literature. The mean age of the patients was 54.9 years, with a male to female ratio of 3:1. The average duration of symptoms was 18.6 months. The appearance of a new growth was the most common symptom. Three patients had stage I disease, one patient each had stage II and III disease, two patients had stage IV disease, and the disease stage was not known in one patient. Five out of these eight patients underwent surgery. Four patients in the treatment group remained disease-free, with a mean survival period of 30 months. In conclusion, regular surveillance with cystoscopy is advised in all cases that had primary closure of the exstrophic bladder.
Adult
;
Biopsy
;
Bladder Exstrophy
;
complications
;
diagnosis
;
surgery
;
Carcinoma, Squamous Cell
;
complications
;
diagnosis
;
surgery
;
Diagnosis, Differential
;
Humans
;
Male
;
Pelvic Exenteration
;
methods
;
Urinary Bladder Neoplasms
;
complications
;
diagnosis
;
surgery
2.Evaluation of Efficacy of Ultrasonography in the Assessment of Transcutaneous Electrical Nerve Stimulation in Subjects with Myositis and Myofascial Pain.
Seema PATIL ; Asha R IYENGAR ; Ramya Madhuri KOTNI ; Subash B V ; Revan Kumar JOSHI
The Korean Journal of Pain 2016;29(1):12-17
BACKGROUND: The study aimed to determine if ultrasonography of masseter can be used to evaluate the outcome of transcutaneous electrical nerve stimulation (TENS) in subjects with temporomandibular disorders (TMDs) such as myositis and myofascial pain. METHODS: Fifteen TMD subjects with myofascial pain/myositis who satisfied the RDC/McNeil criteria were included in the study. All the subjects were administered TENS therapy for a period of 6 days (30 minutes per session). The mouth opening (in millimeters) and severity of pain (visual analogue scale score) and ultrasonographic thickness of the masseter (in millimeters) in the region of trigger/tender areas was assessed in all the subjects both prior and post TENS therapy. A comparison of the pre-treatment and post-treatment values of the VAS score, mouth opening and masseter thickness was done with the help of a t-test. RESULTS: There was a significant reduction in the thickness of masseter muscle (P = 0.028) and VAS scores (P < 0.001) post TENS therapy. There was also a significant improvement in the mouth opening (P = 0.011) post TENS therapy. CONCLUSIONS: In the present study, ultrasonography was found to be an effective measuring tool in the assessment of TENS therapy in subjects with myositis and myofascial pain.
Masseter Muscle
;
Mobility Limitation
;
Mouth
;
Myositis*
;
Pain Measurement
;
Temporomandibular Joint Disorders
;
Transcutaneous Electric Nerve Stimulation*
;
Ultrasonography*